Skip to main contentAll experts

Gary Kanter

CLIN ASO PROF

MD-PSYCHIATRY

  • CLIN ASO PROF
    MD-PSYCHIATRY

GRANTS

  • GRANT
    A Multicenter, 48-week Open-Label Safety Study of Adjunctive Troriluzole in Subjects with Obsessive Compulsive Disorder
    Biohaven Pharmaceuticals25 Jun 2021 - 18 Nov 2022
    Closed
  • GRANT
    A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Troriluzole in Obsessive Compulsive Disorder
    Biohaven Pharmaceuticals13 Apr 2021 - 21 Apr 2023
    Expired
  • GRANT
    A randomized, double-blind, placebo-controlled trial of adjunctive BHV-4157 in Obsessive Compulsive Disorder
    Biohaven Pharmaceuticals16 Feb 2018 - 6 Oct 2023
    Closed